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In a rat model of chronic pancreatitis, activation of P2X7
receptors in spinal microglia contributed to the chronic
visceral hyperalgesia, which was attenuated by intrathecal
administration of brilliant blue G dye, an antagonist of P2X7
receptor.
BACKGROUND & AIMS: Molecular mechanisms underlying the
activated spinal microglia in association with the pain in
chronic pancreatitis (CP) remain unknown. We tested whether
P2X7R on spinal microglia mediates the pathogenesis of
visceral pain using a CP rat model.
METHODS: The CP model was induced via intraductal injection
of 2% trinitrobenzene sulfonic acid into male Sprague-Dawley
rats. Hyperalgesia was assessed based on the mechanical
sensitivity to Von-Frey ﬁlaments (VFFs), and nocifensive be-
haviors were measured in response to electrical stimulation
of the pancreas. Three weeks after CP induction, spinal cord
samples were harvested for immunostaining, immunoblot,
and real-time polymerase chain reaction analyses of the
P2X7R. Changes in nocifensive behaviors and associated mo-
lecular effectors were assessed by blocking spinal cord P2X7R
pharmacologically using the selective P2X7R antagonist bril-
liant blue G (BBG) or genetically using short interfering RNA
(siRNA).
RESULTS: CP induced a signiﬁcant up-regulation of spinal
P2X7R expression, which colocalized with a microglial marker
(OX-42). Intrathecal administration of BBG signiﬁcantly atten-
uated CP-related visceral hyperalgesia in response to VFF-
mediated or electrical stimulation of the pancreas, which
was associated with suppressed spinal expression of P2X7R
and inhibited activation of spinal microglia. Intrathecal
injection of siRNA to knock down P2X7R expression in the
spinal cord would suppress the nociceptive behaviors in CP
rats.
CONCLUSIONS: Spinal microglia P2X7R mediates central
sensitization of chronic visceral pain in CP. BBG may represent
an effective drug for the treatment of chronic pain in CP pa-
tients. (Cell Mol Gastroenterol Hepatol 2015;1:710–720; http://
dx.doi.org/10.1016/j.jcmgh.2015.07.008)Keywords: Brilliant Blue G; Chronic Visceral Pain; Purinergic
Receptors; siRNA Knockdown.
hronic pancreatitis (CP), a disorder characterized byCpersistent inﬂammation, ﬁbrosis, and destruction of
the glandular pancreas, is most commonly caused by
excessive alcohol consumption. Chronic epigastric pain, the
cardinal feature of CP, is typically recurrent, intense, and
persistent. CP-related pain can lead to malnutrition, narcotic
addiction, and major socioeconomic problems. Pain man-
agement in CP remains difﬁcult and frustrating because the
pathogenesis of chronic visceral pain in CP patients is still
under investigation. Opiates are currently the ﬁrst-line
treatment for chronic pain in CP, but opiate therapy is
associated with problematic side effects (i.e., tolerance and
paradoxical hyperalgesia).1
Recently, we demonstrated that the activation of spinal
microglia plays an important role in the initiation and
maintenance of chronic pain in a rodent model of CP.2
Microglia are the primary immune effector cells in the
central nervous system (CNS).3 In response to damage or
injury in the CNS, microglia become activated, thereby
contributing to pain facilitation and visceral hyperalgesia
and allodynia. Despite this understanding, the molecular
mechanism responsible for mediating the activation of spi-
nal microglia that leads to chronic pain remains unclear.
Previous evidence has shown that extracellular adenosine
triphosphate (ATP) released after brain injury initiates
microglial activation via stimulation of purinergic receptors,
which serve as an integral component in the crosstalk
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widely distributed throughout the CNS5 and are classiﬁed
into two subtypes: P2X and P2Y receptors. Among the P2X
receptor family, the involvement of the P2X7 receptor
(P2X7R) in the spinal cord in neuropathic pain has recently
been demonstrated.6 P2X7 gene knockout mice also exhibit
suppressed nociceptive behaviors after both neuropathic
(peripheral nerve injury) and inﬂammatory pain.7,8 The role
of the P2X7R in the pathogenesis of neuropathic/inﬂam-
matory pain has been increasingly explored, but its role in
chronic visceral pain has yet to be determined. As we pre-
viously demonstrated, spinal microglial activation is
important for the initiation and maintenance of chronic
visceral hyperalgesia in a CP rat model. Therefore, we hy-
pothesized that the P2X7R in spinal microglia mediates
chronic visceral hyperalgesia in CP.
Materials and Methods
Animals
Adult male Sprague-Dawley rats (300–400 g) were used
(Laboratory Animal Center, National Yang-Ming University,
Taipei, Taiwan). The rats were housed at a temperature
of 23 ± 3C, maintained on a 12-hour light/dark cycle
(lights on at 7 AM), and provided with standard laboratory
chow and tap water ad libitum. The experiments were
performed during the light period. All protocols were
approved by the Institutional Animal Care and Use Com-
mittee of National Yang-Ming University and Taipei Veter-
ans General Hospital.
Drug Intervention
A total of 0.5 ml of a 2% solution consisting of trini-
trobenzene sulfonic acid (TNBS) (Sigma-Aldrich, St. Louis,
MO) and 10% ethanol in phosphate-buffered saline (PBS) or
vehicle was infused into the pancreatic duct over 2 to 5
minutes as described previously elsewhere.2,9 Brilliant blue
G (BBG; Sigma-Aldrich), a noncompetitive selective antago-
nist of the P2X7R, was dissolved in normal saline (100 mg/
10 mL per rat) for experimental use. Rats from the treatment
group were treated via intrathecal (IT) injection with BBG
or vehicle every 12 hours from the afternoon of the 21st day
to the morning of the 26th day (10 doses) after TNBS or
vehicle administration. To evaluate the “preventive” effect of
BBG on the initiation of visceral hyperalgesia in CP, IT BBG
(100 mg/10 mL per rat) was administered 30 minutes before
TNBS or vehicle administration. Subsequently, an IT injec-
tion of this dose of BBG was performed every 12 hours for 5
consecutive days after the injection of TNBS.
Induction of CP and Electrode Implantation
The rats were anesthetized using isoﬂurane (2%–4%),
and CP was induced as previously described elsewhere.2,9 In
some groups of rats, a pair of electrodes were attached to
the pancreas and then externalized behind the head after
the infusion of the pancreatic duct with vehicle or TNBS. The
animals were returned to their housing environment and
provided with free access to drinking water and standard
food pellets.Surgical Implantation of IT Catheters
The rats were anesthetized via intraperitoneal injection
of sodium pentobarbital (50 mg/kg). The surgical implan-
tation of IT catheters was performed before CP induction.2
Measurement of Visceral Hyperalgesia in CP Rats
Von Frey Filament Assay. The Von Frey ﬁlament (VFF)
assay was performed as previously described elsewhere.2 In
brief, VFFs of six different forces (0.4, 0.6, 1.4, 4, 6, and 10 g;
North Coast Medical, Morgan Hill, CA) were applied to the
abdomen in ascending order 10 times for 1 to 2 seconds per
application, with a 10-second interval between applications.
A positive response consisted of the rat raising its belly
(withdrawal response). All of the assays were performed in
a blinded manner. The IT implantation did not affect the
mechanical sensitivity by VFF assay (please refer to the
results in the supplementary material).
Electrical Stimulation of the Pancreas. The electrical
stimulation procedure was performed as previously
described elsewhere.2 The rats received successive appli-
cations of current at 2, 5, or 10 mA for 5 minutes, with a 10-
minute rest between stimulations. The number of noci-
fensive behaviors observed during the 5 minutes of the
electrical stimulation period were blindly counted by an
assistant. The nocifensive behaviors consisted of stretching,
licking of the limbs and abdomen, contraction of the
abdominal wall muscles, and extension of the hind limbs as
described previously elsewhere.10
Immunohistochemistry
After the completion of the experiments, the rats were
sacriﬁced under anesthesia via intraperitoneal injection of
pentobarbital (100 mg/kg) and then were transcardially
perfused with 100 mL of PBS followed by 500 mL of 4%
paraformaldehyde in ice-cold PBS. The pancreas and the
spinal cord (T8–T12) were removed, postﬁxed for 4 hours
in 4% paraformaldehyde, and cryoprotected over 2 nights in
30% sucrose in phosphate buffer. For the immunohisto-
chemical analysis of the spinal cord, transverse free-ﬂoating
spinal cord sections (30 mm) were generated using a cryo-
stat and processed for immunoﬂuorescence staining. All of
the sections were blocked with 2% donkey serum in 0.3%
Triton-X100 for 1 hour at room temperature and then
incubated overnight at 4C in an antibody for the P2X7R
(1:200; Alomone Labs, Jerusalem, Israel) or OX-42 (CD11b, a
microglial marker; 1:200; Santa Cruz Biotechnology, Hei-
delberg, Germany). Then, the sections were incubated for 1
hour at room temperature in an Alexa 488- or Alexa 594-
conjugated secondary antibody (1:200; Invitrogen/Life
Technologies, Carlsbad, CA). The single-stained images were
examined using an Olympus FV10i confocal microscope
(Olympus, Tokyo, Japan).
For double immunoﬂuorescence staining, the spinal cord
sections were incubated in a combination of the P2X7R,
monoclonal neuron-speciﬁc nuclear protein (NeuN) (a
neuronal marker; 1:100; Chemicon, Temecula, CA), GFAP
(an astrocytic marker; 1:500; Chemicon), and OX-42 (a
microglial marker; 1:100; CiteAb, Raleigh, NC) antibodies
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incubated with 2% bovine serum albumin instead of anti-
bodies. After incubation with primary antibodies or bovine
serum albumin, the sections were rinsed with PBS (three
times for 10 minutes). Sections were subjected to reaction
with Cy2- (1:200; Jackson ImmunoResearch, West Grove,
PA) and Alexa 594-conjugated secondary antibodies for 2
hours at room temperature. This was followed by counter-
staining with DAPI (40,6-diamidino-2-phenylindole; Sigma-
Aldrich) for 5 minutes at room temperature. Sections were
mounted with Vectashield (Vector Laboratories, Burlin-
game, CA). The double-stained images were examined using
an Olympus FV1000 confocal microscope.
Semiquantitative Analysis of Tissue Staining
To quantify positive immunoreactivity in microglia cells
(OX-42) of the superﬁcial dorsal horn, three to ﬁve sections
per animal were selected at random and analyzed. High-
magniﬁcation images were captured with an Olympus
FV10i confocal laser scanning microscope. Positive immu-
noreactivity was quantiﬁed from the superﬁcial dorsal horn
including laminae I and II.
Western Blot Analysis
For Western blot analysis, the groups of rats with or
without TNBS-induced CP were used. After the rats had
been deeply anesthetized via intraperitoneal injection of
pentobarbital (100 mg/kg), the T8–T12 segments of the
spinal cord were rapidly removed and placed on ice to
freeze before extraction. The spinal cords were homoge-
nized in a tissue protein extraction reagent (Thermo Sci-
entiﬁc, Rockford, IL) that contained protease inhibitors and
phosphatase inhibitor cocktail 1/2 (Sigma-Aldrich). Western
blot analysis was performed as described previously else-
where.2 The membranes were blocked for 2 hours in Tris-
HCL buffer solution (TBS) containing 5% bovine serum al-
bumin. After blocking, the membranes were incubated in an
anti-P2X7R antibody (1:1000; Alomone Labs, Jerusalem,
Israel) or an anti-phosphorylated p38 (P-p38) antibody
(1:1000; Cell Signaling Technology, Beverly, MA) in TBS
containing 1% bovine serum albumin overnight at 4C. After
washing in PBS containing 0.5% Tween 20, the membranes
were incubated in a horseradish peroxidase-conjugated
secondary antibody (1:5000; Jackson ImmunoResearch) in
TBS containing 1% bovine serum albumin for 2 hours at
room temperature. The bands were visualized using the
Western Lighting Chemiluminescence Reagent Plus Kit
(PerkinElmer, Waltham, MA), and the band intensities were
measured using a luminescence imaging system. Subse-
quently, the membranes were subsequently stripped and
reprobed for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, 1:5000; Abfrontier, Seoul, Korea). For the quanti-
ﬁcation of Western blot signals, the densities of P2X7R and
P-p38 bands were measured using Multi-Gauge software
(version 3.0; Fujiﬁlm, Tokyo, Japan) and were normalized
against the corresponding GAPDH level as a control for
sample loading. As a consequence, the control needed no
standard error bars, and was stated as being 100%.Quantitative Polymerase Chain Reaction Analysis
The spinal cords were homogenized in TRI reagent
(Sigma-Aldrich), and the total RNA was extracted. After
treatment with the RQ1 RNase-Free DNase kit to remove
contaminating DNA (Promega, Madison, WI), 5 mg of total
RNA was reverse transcribed for 1 hour at 50C using 200
units of SuperScript III reverse transcriptase (Invitrogen).
Then, 200 ng of cDNA was used as the template for real-time
PCR.
The quantitative PCR reactions were performed in trip-
licate using a Roche LightCycler 480 quantitative PCR sys-
tem (Roche Applied Science, Indianapolis, IN). The P2X7R
expression levels were normalized to those of GAPDH.
Quantitative PCR ampliﬁcation was performed as 20 mL
reactions containing 10 mL of X2 SYBR Green I Master Mix
(Roche Applied Science), 0.8 mL of the forward and reverse
primers (mM each), and 9.2 mL of the sample or nuclease-
free water. All reactions were performed in 96-well plates
(LightCycler 480 Multiwell Plates; Roche Applied Science).
The cycling conditions consisted of a 10-minute poly-
merase activation step at 95C, 45 cycles of 95C for 15
seconds, 60C for 15 seconds, and 72C for 25 seconds, and
a dissociation curve analysis step from 60 to 95C. The
relative quantiﬁcation results for both P2X7R and GAPDH
were calculated according to the second derivative
maximum method using LightCycler 480 Software v.1.5
(Roche Applied Science).
Small-Interfering RNA (siRNA)
Small-interfering (siRNA) targeting the rat P2X7R re-
ceptor mRNA sequence containing four pooled SMART
selected duplexes and a nontargeted control siRNA were
obtained (Dharmacon/Thermo Scientiﬁc, Lafayette, CO). The
sense sequences of the four P2X7R-speciﬁc duplexes were
as follows: 1) GUACAGUGGCUUCAAGUAU; 2) GGAUGGACC-
CACAAAGUAA; 3) UUACAGAGGUGGCAGUUCA; and 4)
GAACGAUGUCUUUCAGUAU.11 An siSTABLE control siRNA
was used as the nontargeted control. In the treatment
groups, after the establishment of CP, P2X7R siRNA or
nontargeting siRNA was administered via a single injection
(1.4 nmol/rat) on day 21.
Histologic Examination of the Pancreas
After the required experiments, the rats were sacriﬁced
with pentobarbital (100 mg/kg intraperitoneal injection)
and transcardially perfused with 300 mL of normal saline.
The pancreas were removed and postﬁxed overnight in 10%
formalin solution and embedded in parafﬁn. We stained 4-
mm sections with H&E for histologic examination. Histologic
images were captured with an optical microscope
(Olympus). The specimens were evaluated and scored ac-
cording to the previously published criteria.12
Statistical Analysis
The data are presented as mean ± SEM. The behavioral
data from the VFF and electrical stimulation assays were
analyzed via two-way mixed-design analysis of variance
(ANOVA) followed by Scheffe post hoc analysis (between-
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used to evaluate the intragroup nocifensive behaviors upon
VFF test before and after treatment (within-group analysis).
The Western blot data were analyzed via independent-
sample t test or one-way ANOVA followed by the Tukey
post hoc test. The quantitative PCR and OX-42 semi-
quantiﬁcation data were analyzed via one-way ANOVA fol-
lowed by Scheffe post hoc analysis. P < .05 was considered
statistically signiﬁcant.Results
Trinitrobenzene Sulfonic Acid–Induced Chronic
Pancreatitis Is Associated With Enhanced P2X7R
Expression in Spinal Microglia
First, we examined whether CP induces an up-regulation
of P2X7R in the spinal cord. Immunohistochemical analysis
revealed increased expression of P2X7R in the thoracic
dorsal horn of CP rats compared with control rats
(Figure 1A and B). Western blot analysis also conﬁrmed a
statistically signiﬁcant increase in the P2X7R protein
expression levels in the thoracic spinal cord in the TNBS-
treated group compared with the vehicle-treated group
(P ¼ .0087, Figure 1C). Based on real-time quantitative PCR,
the P2X7R mRNA levels were statistically signiﬁcantly
increased in the TNBS-treated group compared with the
vehicle-treated group (P ¼ .0001, Figure 1D).
P2X7R immunoreactivity colocalized with the OX-42
(microglial marker)–positive cells (Figure 2A and B) butFigure 1. Increased P2X7R
expression levels in the
spinal cord after chronic
pancreatitis (CP). (A) Im-
munohistochemistry of the
spinal cord dorsal horn
in vehicle-treated rats. (B)
Three weeks after induction
of CP, P2X7R expression
was increased. (C) Repre-
sentative Western blots of
P2X7R expression in the
thoracic spinal cord. The
P2X7R expression level was
signiﬁcantly increased after
CP. (D) The P2X7R mRNA
expression level of was
also signiﬁcantly increased
after CP. Scale bar ¼ 100
mm in A and B. *P < .05,
independent-samples t-test.not with the NeuN (neuronal marker)–positive cells
(Figure 2C and D) or the GFAP (astrocytic marker)–positive
cells (Figure 2E and F). These ﬁndings suggested that the
CP-induced up-regulation of the P2X7R in the spinal cord
occurred primarily in microglia.Chronic Pancreatitis–Related Mechanical
Hypersensitivity and Visceral Hyperalgesia Is
Reversed Upon Intrathecal Brilliant Blue G
Administration
We previously showed that TNBS-induced CP leads to
spinal microglial activation. Herein, we examined the po-
tential role of P2X7R on spinal microglial in CP-related
visceral hyperalgesia. The antinociceptive effect of BBG, a
selective P2X7R antagonist, on chronic visceral pain in CP
rats was examined using VFF and electrical stimulation as-
says. After the establishment of CP-related visceral hyper-
algesia, the nociceptive behaviors were reversed by IT
administration of BBG (100 mg/rat, twice daily for 5 days)
based on both assays (P ¼ .0001, Figure 3A and B).Intrathecal Brilliant Blue G Treatment Inhibits the
Up-regulation of P2X7R and the Associated
Spinal Microglial Activation in Rats With Chronic
Pancreatitis
Western blot analysis demonstrated that the enhanced
expression of P2X7R in the TNBS-treated rats was reversed
Figure 2. P2X7R expression with OX-42-positive cells in dorsal horn of the spinal cord. In trinitrobenzene sulfonic acid
(TNBS)-treated rats, P2X7R (red) staining colocalized with OX-42-positive cells (green) (A, B) but not with NeuN-positive cells
(green) (C, D) or GFAP-positive cells (green) (E, F). Double immunoﬂuorescence labeling for P2X7R and for cell-type speciﬁc
markers: NeuN for neuron, GFAP for astrocyte, and OX42 for microglia. DAPI (40,6-diamidino-2-phenylindole) staining identiﬁes
all cell nuclei (blue). Scale bar: 50 mm (A, C, E); 20 mm (B, D, F). The arrows indicate the colocalization of P2X7R expression with
the microglia marker.
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istration, immunohistochemistry revealed a signiﬁcant
decrease in the expression of OX-42 (microglial marker) in
the thoracic dorsal horn of the TNBS-treated CP rats.
Furthermore, in the vehicle-treated rats, the microglia
exhibited a phenotype characteristic of activation
(Figure 4B), whereas the microglia displayed a quiescent
phenotype after BBG treatment (Figure 4C). Western blot
analysis showed statistically signiﬁcantly increased P-p38
expression in the TNBS-treated group, which was reversed
by the IT BBG treatment (Figure 4D, P < .001). This ﬁnding
supported P2X7R on spinal microglia as an important
mediator responsible for nociception in CP rats.
Intrathecal Brilliant Blue G Administration
Prevents the Development of Visceral
Hyperalgesia and the Up-regulation of the P2X7R
in the Spinal Cord After Trinitrobenzene Sulfonic
Acid–Induced Chronic Pancreatitis
To clarify the functional relevance of P2X7R in the
development of chronic visceral pain in CP rats, we exam-
ined whether IT BBG treatment beginning immediatelybefore TNBS administration prevents the development
of visceral hyperalgesia. We performed the IT BBG
administration (100 mg/rat) 30 minutes before TNBS/
vehicle administration. This dose of BBG was injected
every 12 hours for 5 consecutive days after the injection of
TNBS.
In the rats subjected to IT BBG administration 30 mi-
nutes before the infusion of TNBS, no statistically signiﬁcant
differences were detected in the nocifensive responses
based on either the VFF or electrical stimulation assay
compared with the vehicle-treated groups (Figure 5A and
B). In the rats pretreated with vehicle before the infusion of
TNBS, the TNBS-induced visceral hyperalgesia was pre-
served, as illustrated by the increased response frequencies
to VFF stimulation (P ¼ .0001, Figure 5A) and the greater
number of nocifensive behaviors in response to electrical
stimulation of the pancreas (P ¼ .0001, Figure 5B). These
data indicate a critical role of P2X7R expressed in the spinal
cord in the development of chronic visceral pain in CP. In
parallel to the behavioral changes, Western blot analysis
also revealed that BBG administration prevented the up-
regulation of P2X7R in the thoracic spinal cord (P ¼
.0001, Figure 5C).
Figure 3. Brilliant blue G (BBG) treatment alleviated the nocifensive behaviors of trinitrobenzene sulfonic acid (TNBS)–
induced chronic pancreatitis (CP) rats. (A) The abdominal reﬂex based on von Frey ﬁlament (VFF) assays in rats after TNBS
and vehicle treatment (T þ V) was signiﬁcantly increased compared with the control rats (V þ V). Hyperalgesia was alleviated
by intrathecal (IT) injection of BBG (T þ B) (P < .001, mixed-design two-way analysis of variance [ANOVA]). (B) The number of
nocifensive behaviors during electrical stimulation of the pancreas was signiﬁcantly higher in the TNBS-treated rats (T þ V)
than in the control rats (V þ V). Hyperalgesia was alleviated by IT injection of BBG (T þ B) (P < .001, mixed-design two-way
ANOVA). *P < .05 T þ V versus V þ V; #P < .05 T þ B versus T þ V, one way ANOVA followed by Scheffe post hoc analysis.
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Targeting P2X7R to the Spinal Cord Inhibits Both
Visceral Hyperalgesia and the Up-regulation of
P2X7R in the Spinal Cord
To conﬁrm the pharmacologic results, we used an RNA
interference approach. After 3 weeks of CP establishment,
the rats that received an IT injection of nontargeted control
siRNA exhibited signiﬁcant visceral hyperalgesia. However,
IT injection of P2X7R-targeted siRNA signiﬁcantly attenu-
ated visceral hyperalgesia (P ¼.0001, Figure 6A and B). The
P2X7R protein levels were signiﬁcantly decreased in the
P2X7R siRNA-injected rats compared to the control rats
(P ¼ .0001, Figure 6C). In addition, similar results were
detected for the P2X7R mRNA expression levels in the spi-
nal cord (P ¼ .0001, Figure 6D), indicating a substantial and
stable knockdown of P2X7R.Nocifensive behaviors at Baseline, and Before
and After Treatment
The baseline nocifensive behaviors in the absence of any
inﬂammatory insult or after IT catheter implantation were
examined. All rats showed increased frequency responses
(abdominal reﬂex) upon increasing doses of VFF stimuli. No
signiﬁcant difference was noted in the baseline nocifensive
behaviors of the rats in BGG treatment experiments
(Supplementary Figure 1A), BGG prevention experiments
(Supplementary Figure 1B), or siRNA treatment experi-
ments (Supplementary Figure 1C). The within-group com-
parisons of the VFF test before and after treatment are
shown in Supplementary Figures 2–4.Histology of the Pancreas
All rats treated with intraductal injection of TNBS dis-
played typical histopathologic features of CP, as reﬂected by
glandular atrophy, ﬁbrosis, edema, and inﬂammatory cellinﬁltration (Supplementary Figure 5A). No statistically sig-
niﬁcant morphologic changes were identiﬁed after either
BBG or siRNA treatment in CP rats (Supplementary
Figures 5B and C).
Semiquantitative Analysis of Spinal Microglia
In the TNBS-treated rats, semiquantiﬁcation of high-
magniﬁcation immunoﬂuorescence images showed a sta-
tistically signiﬁcant increase in the number of microglia (OX-
42 positive cells) in the superﬁcial spinal dorsal horn; this
increment was reversed by BBG treatment (P < .05,
Supplementary Figure 6).
Discussion
Our study may be the ﬁrst to identify that P2X7R in
spinal microglia is up-regulated in CP and that this up-
regulation is associated with the development of visceral
hyperalgesia. The IT administration of BBG, an antagonist of
the P2X7R, not only attenuated but also prevented CP-
related chronic visceral hyperalgesia. This phenomenon
was associated with a reduction in the P2X7R expression
level in the spinal cord. Genetic manipulation via disruption
of P2X7R signaling using a targeted siRNA also attenuated
the nociceptive behaviors. These data indicate a close as-
sociation between the P2X7R in spinal microglia and chronic
visceral hyperalgesia in CP.
Pain management via the regulation of microglial acti-
vation has recently gained considerable attention in the
study of chronic pain. Moreover, we found that functional
interruption of microglia using minocycline (a microglial
inhibitor) reversed visceral hyperalgesia in a TNBS-induced
CP rat model.2 The molecular and cellular mechanisms un-
derlying microglial activation have gradually been eluci-
dated. For example, several ion channels, such as calcium
and chloride channels,13 modulate membrane potential, the
cell volume, and intracellular ion concentrations, leading to
Figure 4. Brilliant blue G (BBG) treatment attenuated P2X7R expression in the spinal cord. (A) The expression level of
P2X7R in the spinal cord was signiﬁcantly increased in the trinitrobenzene sulfonic acid (TNBS)-treated rats (T þ V) compared
with the control rats (V þ V). P2X7R expression was alleviated by intrathecal (IT) BBG treatment (T þ B) (P ¼ .005, one-way
analysis of variance [ANOVA]). *P < .01, T þ V versus V þ V; #P < .05, T þ B versus T þ V, one-way ANOVA followed by the
Tukey post hoc test. (B) After 3 weeks of TNBS-induced chronic pancreatitis (CP), the vehicle-treated rats exhibited a
microglial activation phenotype based on a microglial marker (OX-42; green). (C) In the BBG-treated rats, the spinal microglia
exhibited a quiescent phenotype. Scale bar: 100 mm. (D) Signiﬁcantly higher P-p38 levels were observed in the TNBS-treated
rats (T þ V) than in the controls (V þ V), and IT BBG reversed the increased P-p38 levels (T þ B). P < .001, one-way ANOVA;
*P < .001, T þ V versus V þ V; #P ¼ .001, T þ B versus T þ V, one-way ANOVA followed by the Tukey post hoc test.
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and cytokine production.14,15 In addition, various signaling
mediators and/or receptors, including fractalkine, inter-
feron-g, monocyte chemoattractant protein-1, P2X4 and
Toll-like receptor 4, were found to be involved in microglial
activation.16 Recently, P2X7R activation via the p38
mitogen-activated protein kinase-early growth response
pathway was found to be responsible for microglia-
mediated inﬂammatory activity, supporting the close asso-
ciation between P2X7R and microglial activation.17
P2X7R is a member of the nonselective cationic channel
family that is gated by extracellular adenosine triphosphate.
Compared with the other P2XR family members, P2X7R
displays a lower afﬁnity for ATP. It has been found that
P2X7R can only be activated under a high concentration
(>100 mM) of its endogenous ligand ATP.18 Thus, it is
conceivable that P2X7R in spinal microglia may be inactive
under physiologic conditions because of an insufﬁcient ATP
concentration in the spinal cord. Our results support thishypothesis because neither pharmacologic antagonism nor
siRNA-mediated inhibition of P2X7R in the spinal cord
decreased the baseline nocifensive behaviors based on VFF-
mediated and electrical stimulation assays.
In our study, TNBS-induced CP was expected to induce
marked inﬂammation and to subsequently generate an ATP-
rich extracellular environment, thereby contributing to the
activation of P2X7R in spinal microglia. Additionally, acti-
vated P2X7R further stimulates the release of both ATP and
glutamate.19 This positive feedback mechanism results in
the sustained activation of P2X7R, thereby contributing to
the persistence as well as the ampliﬁcation of pain. These
phenomena are commonly identiﬁed in chronic pain
patients.
The source of ATP in the spinal cord of current model is
open to discussion. The cytoplasm of most neurons contains
around 2–5 mM of ATP, and even higher concentrations of
ATP (up to 100 mM) are stored in synaptic vesicles.20 Based
on the observation, we speculated that the source of the
Figure 5. Brilliant blue G (BBG) administration prevents visceral hyperalgesia via the inhibition of P2X7R. (A) The mean
abdominal reﬂexes in response to von Frey ﬁlament (VFF) stimulation in trinitrobenzene sulfonic acid (TNBS)-treated rats (V þ T)
were signiﬁcantly higher than in the control rats (V þ V). This effect was prevented by intrathecal (IT) BBG pretreatment (B þ T)
(P < .001, mixed-design two-way analysis of variance [ANOVA]). (B) The number of nocifensive behaviors during electrical
stimulation of the pancreas in the TNBS-treated rats (V þ T) was signiﬁcantly increased compared with the control rats (V þ V).
This effect was prevented by IT BBG pretreatment (B þ T) (P < .001, mixed-design two-way ANOVA). (C) Higher levels of
P2X7R expression were detected in the TNBS-treated group (V þ T) than in the vehicle-treated group (V þ V). The P2X7R
expression level was attenuated by IT BBG pretreatment (B þ T) (P ¼ .014, one-way ANOVA). *P < .05 V þ T versus V þ V;
#P < .05 B þ T versus V þ T, one way ANOVA followed by Scheffe post hoc analysis.
November 2015 P2X7Rs in Chronic Visceral Hyperalgesia 717spinal ATP may be mainly from the primary sensory neuron
in dorsal root ganglion or spinal dorsal horn. Nevertheless,
evidence has suggested that ATP can be also released from
non-neuronal cells such as endothelial cells,21 ﬁbroblasts,22
and astrocytes.23 Further studies are mandatory to clarify
the source of ATP in the spinal cord of CP model.
The expression of P2X7R in the cell types of the CNS has
long been a subject of debate, with inhomogeneous and
contradictory ﬁndings. P2X7R has been reported in neurons,
astrocytes, oligodendrocytes, and Schwann cells.24–26 How-
ever, astrocytes have been found to express only P2X7 re-
ceptor mRNA, but not protein.27 The expression of P2X7R
has been reported in neurons, and P2X7Rs are involved in
modulating neuronal function.28,29 However, “P2X7R-like”
protein staining has been identiﬁed even in P2X7R gene-
knockout mice, which has prompted the question of
whether P2X7Rs are really expressed in neurons.30 By
double-immunohistochemistry staining, we demonstrated
that P2X7 receptors are primarily expressed in spinalmicroglia but not in astrocytes or neurons. Despite these
ﬁndings, functional studies have veriﬁed the expression of
P2X7R on neurons and astrocytes. Thus, we cannot
completely rule out the potential role of neurons or astro-
cytes in mediating the antinociceptive effect in CP rats. More
studies are needed to clarify this issue.
The role of P2X7R in nociception was demonstrated
using P2X7R-deﬁcient mice, which exhibited attenuated
thermal and mechanical hypersensitivity after partial sciatic
nerve ligation.8 Furthermore, pharmacologic blockade of
P2X7R via intraperitoneal administration of the selective
inhibitors of P2X7R A-740003 (N-[1-[(E)-[(cyanoamino)-
(quinolin-5-ylamino)methylidene]amino]-2,2-
dimethylpropyl]-2-(3,4-dimethoxyphenyl)acetamide) and A-
438079 (3-[[5-(2,3-dichlorophenyl)tetrazol-1-yl]methyl]
pyridine) reduced tactile allodynia in three different rat
models of neuropathic pain.6
Two recent studies provided further evidence demon-
strating the role of spinal microglial P2X7R in chronic pain.
Figure 6. Intrathecal (IT) administration of P2X7R-targeted small-interfering RNA (siRNA) ameliorated the chronic
pancreatitis (CP)-related nocifensive behaviors. (A) The abdominal reﬂex in response to von Frey ﬁlament (VFF) stimulation
in rats after intraductal infusion of TNBS and nontargeted siRNA treatment (T þ N) was signiﬁcantly increased compared with
the control rats (V þ N). This hyperalgesia was ameliorated by IT injection of P2X7R siRNA (T þ KD) (P < .001, mixed-design
two-way analysis of variance [ANOVA]). (B) The number of nocifensive behaviors during electrical stimulation of the pancreas
was signiﬁcantly higher in the trinitrobenzene sulfonic acid (TNBS)-treated rats (T þ N) than in the control rats (V þ N).
Hyperalgesia was be ameliorated by IT injection of P2X7R siRNA (T þ KD) (P < .001, mixed-design two-way ANOVA). (C)
P2X7R expression in the spinal cord was signiﬁcantly increased in the TNBS-treated CP rats (T þ N) compared with the control
rats (V þ N). The P2X7R expression level was decreased by IT administration of P2X7R-targeted siRNA (T þ KD). (D) The
P2X7R mRNA level was signiﬁcantly increased in the TNBS-treated rats (T þ N) compared with the control rats. IT injection of
P2X7R-targeted siRNA (T þ KD) down-regulated the P2X7R mRNA level in the spinal cord of CP rats. *P < .05 T þ N versus
V þ N; #P < .05 T þ KD versus T þ N, one-way ANOVA followed by Scheffe post hoc analysis.
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pression in spinal microglia is markedly increased after
peripheral nerve injury and that the associated mechanical
hypersensitivity was attenuated by IT administration of A-
438079. In a chronic pain model consisting of chronic
constriction of the sciatic nerve in rats, He et al32 showed
that IT BBG administration reduced both nociceptive be-
haviors and the OX-42 levels in the dorsal horn of the spinal
cord. To date, the role of spinal microglial P2X7R in the
pathogenesis of visceral pain remains unexplored, and we
may be the ﬁrst to report that spinal microglial P2X7R
mediates visceral hyperalgesia in a CP rat model.
BBG, an analog of FD&C blue dye no. 1, is a commonly
used selective P2X7R antagonist. Its low toxicity and high
selectivity make BBG an ideal candidate for blocking the
potential adverse effect of P2X7R activation in various ani-
mal models. One study investigating neuropathic pain also
demonstrated that BBG would down-regulate the P2X7R
expression in the spinal dorsal horn.33 In addition, BBG hasbeen shown to suppress the expression of P2X7R in
different models, such as stab wound injury,4 optic nerve
crush injury,34 pressure-induced retinal ganglion cell
death,35 and myocardial ischemia.36 The detailed molecular
mechanism behind this common ﬁnding is unclear and may
deserve future exploration.
When we administered BBG by intraperitoneal injection
in the CP model, we found that BBG would attenuate
visceral hyperalgesia in CP rats (results not shown). BBG is
capable of permeating the blood–brain barrier. Therefore,
systemic administration may represent a feasible route of
administration of BBG for future treatments of neuro-
inﬂammatory diseases/processes in the CNS. We have
limited our report to the results of the IT route of admin-
istration rather than the systemic BBG administration
because P2X7R expression is not conﬁned to spinal micro-
glia, but rather is widely distributed throughout various cell
types in multiple organ systems. We speciﬁcally focused on
the results of IT BBG injection in the current model to
November 2015 P2X7Rs in Chronic Visceral Hyperalgesia 719provide a more speciﬁc demonstration of the role of P2X7R
in spinal microglia, rather than the nonspeciﬁc targeting of
P2X7R via systemic administration.
BBG has been found to inhibit voltage-gated sodium
channels,37 which are involved in the pathogenesis chronic
visceral pain.38 This observation indicates that BBG, in
addition to inhibition of P2X7R, may also alleviate noci-
fensive behaviors in CP rats by inhibition of the voltage-
gated sodium channel.37
The VFF scores in Figure 5 were lower for CP-vehicle
group than seen in the other ﬁgures (Figures 3 and 6),
especially for the stimuliwith lower intensities (0.4 and0.6 g).
The experimental conditions shown in Figure 5 were
slightly different from those seen in Figures 3 and 6.
Figure 5 shows the results in association with the “preven-
tion” effect of BBG, whereas Figures 3 and 6 are represen-
tative the ‘treatment’ effect of BBG and P2X7R siRNA. In our
evaluation of prevention effect of BBG, the rats were sent to
experiments without manipulation; an IT injection of normal
saline (vehicle) was given before the behavior test in the CP-
vehicle rats. We speculated that this manipulation might
sensitize the spinal cord and lead to higher VFF scores.
In conclusion, P2X7R expression in spinal microglia is
signiﬁcantly up-regulated in the TNBS-induced CP rat
model, and this up-regulation is associated with visceral
hyperalgesia. Both pharmacologic and genetic blockade of
P2X7R attenuated visceral hyperalgesia in CP, suggesting
that BBG treatment may represent an effective therapeutic
strategy by targeting P2X7R in spinal microglia.References
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Figure 1. The abdominal
reﬂex upon von Frey ﬁla-
ment (VFF) stimuli in
baseline showed no sig-
niﬁcant difference among
the four groups (mixed-
design two-way analysis
of variance) in (A) brilliant
blue G (BBG) treatment
experiments (P [ .792);
(B) BBG prevention ex-
periments (P [ .401); and
(C) P2X7R small-
interfering RNA (siRNA)
treatment experiments
(P [ .247).
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Figure 2. Brilliant blue G
(BBG) treatment experi-
ment. (A, B, D) Within-
group analysis in the BBG
treatment experiments
showed the abdominal re-
ﬂexes upon von Frey ﬁla-
ment (VFF) stimuli were
similar before and after
BBG/vehicle treatment.
(C) In the TNBS-induced
chronic pancreatitis (CP)
rats, the abdominal reﬂexes
upon VFF stimuli were
signiﬁcantly increased after
vehicle treatment. Analysis
by two-way repeated mea-
surement analysis of vari-
ance) (A) P ¼ .363; (B)
P ¼ 1.0; (C) *P ¼ .002; (D)
P ¼ .781.
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Figure 3. Brilliant blue G
(BBG) prevention experi-
ment. (A, B, D) Within-
group analysis in the
brilliant blue G (BBG)
prevention experiments
showed the abdominal re-
ﬂexes upon von Frey ﬁla-
ment (VFF) stimuli were
similar before and after
BBG/vehicle prevention.
(C) In the rats with trini-
trobenzene sulfonic acid
(TNBS)-induced chronic
pancreatitis (CP), the
abdominal reﬂexes upon
VFF stimuli were signiﬁ-
cantly increased after
vehicle prevention. Anal-
ysis by two-way repeated
measurement analysis of
variance. (A) P ¼ .732; (B)
P ¼ .248; (C) *P < .001; (D)
P ¼ .199.
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Figure 4. P2X7R small-
interfering RNA (siRNA)
treatment experiment.
(A, B, D) Within-group
analysis in the brilliant
blue G (BBG) treatment
experiments showed the
abdominal reﬂexes upon
von Frey ﬁlament (VFF)
stimuli were similar before
and after P2X7R siRNA/
nontargeted siRNA treat-
ment. (C) In the trini-
trobenzene sulfonic acid
(TNBS)-induced chronic
pancreatitis (CP) rats, the
abdominal reﬂexes upon
VFF stimuli were signiﬁ-
cantly increased after
nontargeted siRNA treat-
ment. Analysis by two-way
repeated measurement
analysis of variance. (A)
P ¼ .391; (B) P ¼ .069; (C)
*P ¼ .007; (D) P ¼ .222.
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Supplementary
Figure 5. Pancreatic his-
tology in chronic pancre-
atitis (CP) rats treated
with vehicle (A), brilliant
blue G (BBG) (B), and
P2X7R small-interfering
RNA (siRNA) (C). All
groups of rats showed
markedly inﬂammatory
cells inﬁltration, large re-
gions of acinar loss and
periductular and intra-
lobular ﬁbrosis, and lost
acinar tissue replaced with
tubular structures. No
signiﬁcant morphologic
changes could be
observed after either BBG
or siRNA treatment in CP
rats. H&E stain; scale bar:
100 mm.
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Supplementary Figure 6. Semiquantitative analysis
showed that OX-42-positive cells in the superﬁcial lamina
of the spinal dorsal horn signiﬁcantly increased in trini-
trobenzene sulfonic acid (TNBS)-induced chronic
pancreatitis (CP) rats and that brilliant blue G (BBG) would
signiﬁcantly reduce the numbers of microglia cells. P ¼
.002, by one-way analysis of variance (ANOVA). *P ¼ .008:
V þ V versus T þ V; #P ¼ .007: T þ V versus T þ B, one-way
ANOVA followed by Scheffe post hoc analysis.
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